Alembic Pharma Net profit rises 25 percent to Rs 293 crore in Q3
"It was another good quarter for the company led by strong growth in the India formulation business. The API Business continued to perform well in the current quarter," Alembic Pharmaceuticals Managing Director Pranav Amin said.
New Delhi: Drug firm Alembic Pharmaceuticals on Tuesday reported a 24.92 percent rise in its consolidated net profit to Rs 292.57 crore for the December quarter mainly on account of robust sales.
The company had posted a net profit of Rs 234.19 crore for the corresponding period of the previous financial year, Alembic Pharmaceuticals said in a regulatory filing.